# Sugammadex Improves Muscle Function After Standard Neuromuscular Recovery

> **NCT01101139** · PHASE4 · COMPLETED · sponsor: **Technical University of Munich** · enrollment: 300 (actual)

## Conditions studied

- Neuromuscular Blockade

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01101139
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-05
- **Final completion:** 2011-06
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2012-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101139, "Sugammadex Improves Muscle Function After Standard Neuromuscular Recovery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01101139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*